Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer ...

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...

A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...

Hospitals struggling to attract and retain enough registered nurses at the bedside are implementing alternative strategies to ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...

A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle ...

Ultra-processed foods (UPFs) are a leading cause of the "chronic disease pandemic" linked to diet, with food firms putting ...

A California company, Okava Pharmaceuticals, has launched a clinical trial testing a GLP-1–based weight loss treatment in 50 ...

A new study by Phoenix's Barrow Neurological Institute and the University of Calgary has found which injectable treatments showed the most benefit for migraine patients and should be routinely offered ...

For years, the search for a stem cell donor has felt like a quest for a rare key—one that fits a lock with eight intricate tumblers, each representing a genetic marker. For many patients with blood ...